無料セミナー : 2020年3月4日『Future of Immuno-Oncology 免疫腫瘍学の未来』 DelveInsight Business Research共同開催

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

閉鎖式薬剤移行システム

Closed System Drug Transfer Devices

発行 Greystone Research Associates 商品コード 135878
出版日 ページ情報 英文
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=111.33円で換算しております。
Back to Top
閉鎖式薬剤移行システム Closed System Drug Transfer Devices
出版日: 2017年12月01日 ページ情報: 英文
概要

人間に有害とされる薬剤の投与は、その物質の危険性が明確に理解されるようになり、精査の量が増加しています。その最前線の治療分野が臨床腫瘍学で、細胞毒性医薬品への暴露を軽減するための試みが行われています。

当レポートでは、腫瘍の治療市場における細胞毒性医薬品の影響と安全性について調査分析し、市場の動向と人口動態、閉鎖式薬剤移行製品の分析、需要促進要因、競合要因について検証するほか、主要企業、製品開発、ビジネス戦略などについて、体系的な情報を提供しています。

エグゼクティブサマリー

細胞毒性医薬品による治療市場の動向

  • 治療動向と問題点
  • 注入型/点滴型抗腫瘍薬の投与
  • 医薬品包装と投与技術
  • 閉鎖式薬剤移行市場の促進要因
  • 競合情勢
  • 危険因子

閉鎖式薬剤移行の設計要素

  • 主なシステム設計要素
  • ヒトエンジニアリング/エルゴノミクス
  • 物質選定の問題点
  • 薬剤の再構築と希釈
  • がん治療薬の安全性
  • がん治療薬の投与と用量
  • 薬剤ごとの用量設定と個人の用量設定

閉鎖式薬剤移行 - 商用デバイスの評価と市場データ

  • ChemoCLAVE
  • EquaShield
  • OnGuard
  • PhaSeal
  • Texium/SmartSite
  • その他の閉鎖式薬剤移行デバイス

市場要素

  • 規制上の問題点
  • 介護者の適合性
  • 複雑さのレベルと使いやすさ
  • 医療経済
  • ビジネスモデルと戦略

市場評価と予測

  • 北米
  • 欧州
  • アジア
  • その他の地域市場

閉鎖式薬剤移行 - 市場参入企業プロファイル

目次
Product Code: DTS555D17

Interest in closed system drug transfer devices has been growing as regulatory activity and practitioner awareness surrounding hazardous drug compounding and administration continue to increase. Drugs deemed hazardous to humans has been receiving increasing amounts of scrutiny in recent years as the dangers of these substances become more clearly understood. For caregivers and their patients, the therapeutic area that is at the forefront of attempts to mitigate exposure to cytotoxic drugs is clinical oncology, a field that - in spite of promising new drugs based on therapeutic antibodies - continues to rely heavily on antineoplastics, a class that includes alkylating agents and antimetabolites, to treat a wide range of cancers. Regulatory and industry efforts to create standards and procedures for closed system drug transfer devices are designed to protect workers and patients from accidental and incidental exposure to cytotoxics are being driven by data that suggests a causal link between exposure and health issues. This report analyzes devices, regulations, markets and participants competing in the closed system drug transfer device segment and provides insight, analysis, assessments and forecasts to assist readers in navigating this rapidly evolving sector.

Closed System Drug Transfer Devices - What You Will Learn:

  • What are the key segments and addressable markets that comprise the market for cytotoxic drug delivery?
  • What are the major therapeutic demand drivers for cytotoxic drug therapeutics?
  • What are the design factors and technologies that are being used in commercial and development-stage closed drug transfer systems?
  • What is the market share and product position in the market and what will it look like in 2024?
  • Who are the companies behind the current generation of cytotoxic transfer devices and what are their business models?
  • What is the role of pharma-device alliances and design partnerships in the commercialization and market access of new and emerging closed system drug transfer devices?
  • What is the impact of economic, technology, and regulatory factors on CSDT device demand?

Table of Contents

Summary of Contents

Evolution in Oncology Therapeutics

  • Recombinant Drugs & Personalized Medicine
  • The Growth of Targeted Therapeutics
  • The Evolving Role of Cytotoxic Drugs
  • The Administration of Antineoplastics
  • Closed System Drug Transfer (CSDT) Demand Drivers
  • Regulatory Factors
  • Market Factors
  • Technology Factors
  • Regional Factors
  • CSDT Competitive Landscape
  • Risks and Opportunities

The Market for Cytotoxic Drugs

  • Usage Trends
  • Evolving Prescribing Factors
  • Special Considerations

Closed System Drug Transfer Design Factors

  • Oncology Therapeutics Medication Safety
  • Material Selection Issues
  • Drug Reconstitution
  • Oncology Drug Administration and Dosing
  • Drug-Specific Dosing Modification and Individualized Dosing
  • CSDT Device Performance Factors
  • Vapor Containment
  • Testing Protocols

CSDT Devices - Key Market Segments

  • Teaching Hospitals
  • Regional Hospital
  • Oncology Centers/Clinics

Closed System Drug Transfer - Device Assessments

  • Device Configuration
  • Device-to-Device interface
  • User-to-Device Interface
  • Device Sharps Strategy
  • Device Compliance Performance

Market Factors

  • Regulations and Standards
  • CDC/NIOSH
  • HOPA
  • ISMP
  • USP 800
  • ISOPP
  • Caregiver Compliance
  • Level of Complexity and Ease of Use
  • Healthcare Economics
  • Business Models and Strategies

Market Assessments and Forecasts

  • North America
  • Europe
  • Asia
  • Other Geographic Markets

Company Profiles

Back to Top